Evidence map›Paper›PMID 23813935›Full record

ArticleBlood2013

Antiviral cell therapy: is this the future?

Juan C Gea-Banacloche

3 registry-linked trialsAbstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07670468 phase1 / phase2recruitingnot on this mapstarted 2025, after this paper: background citation

A Single-Center, Open-Label, Phase 1/2 Clinical Trial to Evaluate the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.

TypeinterventionalSponsorLucasBioRan2025 to 2027Enrolled27ConditionsBKV Infection, EBV Infection, CMV InfectionArmsLB-DTK-MV
NCT07679412 narecruitingnot on this mapstarted 2026, after this paper: background citation

An Exploratory Clinical Study of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.

TypeinterventionalSponsorLucasBioRan2026 to 2027Enrolled5ConditionsCMV RetinitisArmsLB-DTK-CMV
NCT07685457 narecruitingnot on this mapstarted 2026, after this paper: background citation

A Prospective Clinical Study to Evaluate the Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.

TypeinterventionalSponsorLucasBioRan2026 to 2027Enrolled6ConditionsBKV Infection, CMV Infection, EBV InfectionArmsLB-DTK-MV
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Juan C Gea-BanaclocheNational Cancer Institute.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adenoviridae InfectionsCytomegalovirus InfectionsEpstein-Barr Virus InfectionsFemaleGraft vs Host DiseaseHematologic NeoplasmsHematopoietic Stem Cell TransplantationHumansMaleT-Lymphocytes, Cytotoxic

Identifiers

PMID23813935
PMCPMC3695358

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.